IVIG-SN 10%

· Green Cross Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IVIG-SN 10%, covering 2020-05-21 to 2020-05-21. Get the full timeline:

Most recent: Clinical Trial Update: Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki Disease [Phase 4]